Clinical Trials Sponsored by MiraDX
Total 169 results
-
Jonsson Comprehensive Cancer CenterMiraDXActive, not recruitingProstate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
miraDry, Inc.Withdrawn
-
Amir Moradi MD, MBAAllerganNot yet recruiting
-
LumiraDx UK LimitedNot yet recruitingSARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza BUnited States
-
Mirati Therapeutics Inc.RecruitingMetastatic Lung Cancer | Advanced NSCLCUnited States, Spain, Greece, Hungary, France, Italy, Poland
-
LumiraDx UK LimitedRecruitingInfections | Inflammation | Embolism and Thrombosis | Cardiovascular | RenalUnited Kingdom
-
Mirati Therapeutics Inc.RecruitingPancreatic Adenocarcinoma | Solid Tumor | Non Small Cell Lung Cancer | Mesothelioma | Advanced Solid Tumor | Malignant Peripheral Nerve Sheath TumorsUnited States
-
LumiraDx UK LimitedRecruitingInfluenza, Human | Respiratory Syncytial Virus InfectionsUnited States
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
Mirati Therapeutics Inc.Active, not recruitingMetastatic Colorectal Cancer | Advanced Colorectal CancerUnited States, Denmark, Finland, Italy, Spain, Belgium, Romania, Taiwan, Thailand, France, Germany, Korea, Republic of, China, Malaysia, Hong Kong, Australia, Austria, Puerto Rico, Singapore, Canada, Portugal, Poland, Greece, United Kingdom and more
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
LumiraDx UK LimitedCompleted
-
LumiraDx UK LimitedSuspended
-
LumiraDx UK LimitedCompletedInfections | Inflammation | Tissue InjuryUnited Kingdom
-
Mirati Therapeutics Inc.CompletedHepatic ImpairmentUnited States
-
Mirati Therapeutics Inc.Approved for marketingMetastatic Cancer | Advanced Cancer | Malignant NeoplasmUnited States
-
Mirati Therapeutics Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States
-
LumiraDx UK LimitedActive, not recruitingDeep Vein Thrombosis | Venous Thromboembolism | Pulmonary EmbolismUnited Kingdom, Germany
-
MiMedx Group, Inc.CompletedTendonitis;AchillesUnited States
-
MiMedx Group, Inc.TerminatedPharynx Cancer | Larynx Cancer | Pharyngocutaneous FistulaUnited States
-
Mirati Therapeutics Inc.CompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Hungary, United Kingdom, Italy, Australia, Taiwan, Poland, Canada
-
LumiraDx UK LimitedCompletedAnticoagulants and Bleeding DisordersGermany
-
MiMedx Group, Inc.CompletedShoulder Injury | Supraspinatus Tear | Shoulder SprainUnited States
-
LumiraDx UK LimitedCompletedAtrial Fibrillation | Thrombophilia | Deep Vein Thrombosis | Antiphospholipid Syndrome | Pulmonary Embolism | Post-Myocardial Infarction Syndrome | Artificial Heart Device UserUnited Kingdom
-
MiMedx Group, Inc.CompletedDiabetic Foot UlcerUnited States
-
MiMedx Group, Inc.Completed
-
MiMedx Group, Inc.Completed
-
MiMedx Group, Inc.CompletedOsteoarthritis of the KneeUnited States
-
MiMedx Group, Inc.Completed
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphocytic Leukemia, ChronicUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphomaUnited States, Canada
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
MiMedx Group, Inc.CompletedAdhesions of Soft TissueUnited States
-
Mirati Therapeutics Inc.TerminatedStomach Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Prostate Cancer | Non-Small-Cell Lung Carcinoma | Prostatic Cancer | Pulmonary CancerUnited States
-
MiMedx Group, Inc.Terminated
-
MiMedx Group, Inc.CompletedComparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar FasciitisPlantar FasciitisUnited States
-
Leiden University Medical CenterMirada MedicalCompleted
-
Mirati Therapeutics Inc.RecruitingMetastatic Cancer | Advanced Cancer | Malignant Neoplasm of LungKorea, Republic of, United States, Turkey, France, Taiwan
-
Mirati Therapeutics Inc.RecruitingPancreatic Adenocarcinoma | Solid Tumor | Advanced Solid Tumor | Non-small Cell Lung Cancer | Colo-rectal CancerUnited States
-
Mirati Therapeutics Inc.RecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Colo-rectal CancerUnited States, Puerto Rico
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Mirati Therapeutics Inc.RecruitingMetastatic Cancer | Advanced Cancer | Malignant Neoplastic DiseaseUnited States, Puerto Rico
-
LumiraDx UK LimitedSuspendedCovid19 | RSV Infection | Influenza Type B | Influenza Type AUnited Kingdom
-
LumiraDx UK LimitedActive, not recruitingInflammation | Embolism and Thrombosis | InfectionUnited States
-
Mirati Therapeutics Inc.CompletedClear Cell Renal Cell CarcinomaUnited States
-
Mirati Therapeutics Inc.TerminatedUrothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Carcinoma Ureter | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma UrethraUnited States
-
LumiraDx UK LimitedCompletedCOVID-19 | Influenza A | RSV Infection | Influenza Type BUnited States
-
LumiraDx UK LimitedSuspendedCOVID-19 | SARS-CoV-2 | Influenza A | Influenza BUnited States
-
Mirati Therapeutics Inc.Completed